ADMA Biologics is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma based biologics for the treatment and prevention of certain infectious diseases. Our targeted patient populations include immune compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune suppressed for medical reasons. Our product candidates are intended to be used by physician specialists focused on caring for immune compromised patients with infectious diseases. ADMA also operates ADMA BioCenters, an FDA licensed, GHA certified source plasma collection facility which provides a portion of blood plasma for the manufacture of the our lead product candidate RI .
Quote | ADMA Biologics Inc (NASDAQ:ADMA)
Last: | $6.20 |
---|---|
Change Percent: | 0.0% |
Open: | $6.1999 |
Close: | $6.20 |
High: | $6.29 |
Low: | $6.1 |
Volume: | 1,378,840 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | ADMA Biologics Inc (NASDAQ:ADMA)
2024-04-16 21:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-03 06:00:00 ET Summary ADMA Biologics' stock has seen a significant rally, fueled by growth in plasma-derived biologics and improved financial health. Recent earnings highlight revenue growth, operational efficiencies, and a shift towards profitability, with notable progre...
Message Board Posts | ADMA Biologics Inc (NASDAQ:ADMA)
Subject | By | Source | When |
---|---|---|---|
$ADMA Adma Biologics Inc | mick | investorshub | 04/30/2023 9:11:34 PM |
ad-ma $ADMA | mick | investorshub | 04/15/2023 3:16:50 PM |
$ADMA Adma Biologics Inc | mick | investorshub | 02/27/2023 12:15:20 AM |
Looks like a double pointed top forming I | bude | investorshub | 02/09/2023 3:08:09 PM |
Look at the weekly and monthly charts for | bude | investorshub | 02/09/2023 1:42:24 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-16 21:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Moderna (NASDAQ: MRNA) rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157...
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life Extends the Prior Room Temperature Storage Allowance for the Full 36-months for ASCENIV and BIVIGAM Provides for Improved Inventory Ma...